APA (7th ed.) Citation

AH, S., T, B., A, D., A, Z., M, A., AS, C., . . . DJ, C. (2022). Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia. The Annals of pharmacotherapy, 56(7), 753. https://doi.org/10.1177/10600280211044160

Chicago Style (17th ed.) Citation

AH, Szeto, et al. "Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia." The Annals of Pharmacotherapy 56, no. 7 (2022): 753. https://doi.org/10.1177/10600280211044160.

MLA (9th ed.) Citation

AH, Szeto, et al. "Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia." The Annals of Pharmacotherapy, vol. 56, no. 7, 2022, p. 753, https://doi.org/10.1177/10600280211044160.